Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In the LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results), researchers found that liraglutide reduced the risk of cardiovascular events in diabetic patients, including heart attack, stroke, and cardiovascular death, by 13% compared to placebo
This is probably the question patients worry about most
If symptoms are severe or you experience signs of a medical emergency, seek immediate medical attention
This article is informational and does not constitute medical advice.
Some patients may choose to lower their dose to see if they can maintain their weight at a reduced strength
US$ 23.94
US$ 27.31
US$ 24.44
US$ 28.61
US$ 22.83
